Oncologix Tech

Oncologix Tech EPS

Delisted·Sep 9, 2026

Earnings per Share (EPS) of Oncologix Tech (OCLG) as of Nov 4, 2026.

EPS

-0.00USD

YoY

22.24%

Last updated:

Earnings per Share (EPS) of Oncologix Tech is 2017 -0.00 USD. Earnings per Share (EPS) of Oncologix Tech was 2016 -0.00 USD. It decreases by 22.24% lower compared to the previous year.

The Oncologix Tech EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2010
-0.02 USD
Jan 1, 2011
-0.00 USD
Jan 1, 2012
-0.00 USD
Jan 1, 2013
-0.01 USD
Jan 1, 2014
-0.01 USD
Jan 1, 2015
-0.00 USD
Jan 1, 2016
-0.00 USD
Jan 1, 2017
-0.00 USD
The Oncologix Tech EPS history
YEAREPSYoY
-0.00USD+22.24%
-0.00USD-34.21%
-0.00USD-61.18%
-0.01USD+19.37%
-0.01USD+67.15%
-0.00USD+10.11%
-0.00USD-71.47%
-0.02USD-89.57%
-0.15USD-4.31%
-0.16USD-63.08%
-0.43USD+5.30%
-0.40USD-99.40%
-67.89USD+10,050.27%
-0.67USD-1.67%
-0.68USD-43.21%
-1.20USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncologix Tech Stock analysis

What does Oncologix Tech do? Oncologix Tech, Inc. generates revenue through the operation and manufacture of medical device products. The company collaborates with manufacturers and stakeholders in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers. It reviews licenses and sublicense agreements with potential licensors and conducts research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. Oncologix Tech, Inc. seeks additional acquisitions of diagnostic and biotechnology opportunities to expand its portfolio. The firm's primary customers include partners, customers, vendors, and manufacturers within the medical device and biotech sectors. It targets opportunities in diagnostic and biotechnology fields through strategic acquisitions and partnerships. Oncologix Tech, Inc. focuses on executing agreements and conducting due diligence to secure new ventures in the biotech industry. Oncologix Tech, Inc. operates as a medical holding company with a focus on medical device products. It engages in reviewing licenses and sublicense agreements and conducts research on potential acquisitions. The company aims to expand its operations by acquiring diagnostic and biotechnology opportunities in the market. Oncologix Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncologix Tech stock

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Oncologix Tech since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Oncologix Tech

All Key Metrics — Oncologix Tech